Sales revenues for February 2025

Sofia, Bulgaria, March 20, 2025 – According to the requirements of Art. 100t of the Law on Public Offering of Securities (LPOS), “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies, that for February 2025 the Company recorded a decrease in sales of 35% compared to the same month of the previous year, incl. 28% decrease in domestic sales and 42% decrease in export sales due to upcoming campaigns and logistical reasons respectively.

For the period from the beginning of 2025, the Company realized a 10% decrease in sales, including a 11% decrease in domestic sales and a 10% decrease in export sales.